-The Times of India PUNE: The much-anticipated extension of the Right of Children to Free and Compulsory Education (RTE) Act, 2009, to the pre-school and secondary education may still take time to come through. The act, which at present covers primary and upper primary schools, provides for free and compulsory education to children between the ages of six and 14 and directs government, aided and non-minority unaided schools to reserve 25% of...

-IPS News Environmental activists are cautiously optimistic that a call by a court-appointed technical committee for a ten-year moratorium on open field trials of genetically modified (GM) crops will shelve plans to introduce bio-engineered foods in this largely agricultural country. “We are now waiting to see whether the Supreme Court will accept the recommendations of its own committee at the next hearing on Oct. 29,” said Devinder Sharma, chairman of the Forum...

-The Hindu Tamil Nadu’s Solar Energy Policy can go a long way in addressing the supply-demand mismatch The State’s solar initiative can draw on the strengths of its robust wind power programme Is the sun the answer to Tamil Nadu’s power crisis? With the unveiling of the Solar Energy Policy last week, Tamil Nadu joins the long list of States trying to find a way of harnessing this source of renewable energy...

-The Economic Times Nazia is 10 years old. But, according to a claim filed by Chhattisgarh-based Shaheed Hospital with the Rashtriya Swasthya Bima Yojna (RSBY), she has delivered a baby after a caesarean operation. Mukul (name changed) is only 7. But Agarwal Hospital, Raipur, has made a claim for removing cataract from his eyes. A large number of similar implausible claims, being made by private hospitals enrolled to treat poor patients under...

-Live Mint There are also ways in which we can help Indian institutions that have come to us seeking access to our technologies Bangalore: A key perception change is emerging in the global pharmaceutical industry on the long-established divide between the so-called generics and innovative business. While the two are still at loggerheads in several developed as well as developing markets, the world’s top drugmakers are reinventing the wheel. Paris-based Sanofi SA,...